We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Prana's PBT2 Phase II Trial Receives Funding From Alzheimer's Drug Discovery Foundation

Product News   Apr 04, 2011

 
Prana's PBT2 Phase II Trial Receives Funding From Alzheimer's Drug Discovery Foundation
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Product News

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

READ MORE

Cytel Announces East Alloy: Easy Access to Bayesian and Innovative Methods

Product News

Cytel has announced the launch of East Alloy®, a web-native extension of Cytel’s East® software for adaptive clinical trial design and analysis.

READ MORE

Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

Product News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE